English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12500/13673 (91%)
Visitors : 2572748 Online Users : 481
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
細胞及系統醫學研究所
褚志斌
--會議論文/會議摘要
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
細胞及系統醫學研究所
>
褚志斌
>
會議論文/會議摘要
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Loading...
Siblings
圖書
[
0
/1]
專利
[
0
/1]
期刊論文
[
98
/99]
Collection Statistics
近3年內發表的文件:4(17.39%)
含全文筆數:19(82.61%)
文件下載次數統計
下載大於0次:19(100.00%)
下載大於100次:15(78.95%)
檔案下載總次數:4628(9.16%)
最後更新時間: 2025-04-27 16:27
上傳排行
資料載入中.....
下載排行
資料載入中.....
最近上傳
Dual and opposing roles of androgen...
CAPE combined with Cisplatin or Doc...
Identifying serum biomarkers for pr...
Combination of CAPE with enzalutami...
Caffeic acid phenethyl ester suppre...
Aspalathus linearis suppresses AKT ...
ACTL6A is a novel oncogene and prog...
Histone demethylase KDM4C is a nove...
The anti-proliferative effect of CA...
ACTL6a promotes metastasis and pred...
跳至:
(選擇年份)
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(選擇月份)
January
February
March
April
May
June
July
August
September
October
November
December
或輸入年份:
由新到舊排序
由最舊的開始
顯示項目1-23 / 23. (共1頁)
1
每頁顯示[
10
|
25
|
50
]項目
日期
題名
關聯
2024-03
Combination of CAPE with enzalutamide or abiraterone suppresses drug-resistant prostate cancer via AR-V7 degradation
Cancer Science. 2024 Mar;115(Suppl. 1):316.
2024-03
Identifying serum biomarkers for predicting the resistance of enzalutamide or abiraterone in prostate cancer patients
Cancer Science. 2024 Mar;115(Suppl. 1):329.
2024-03
CAPE combined with Cisplatin or Docetaxel inhibits the survival and proliferation of non-small cell lung cancer cells
Cancer Science. 2024 Mar;115(Suppl. 1):959.
2024-03
Dual and opposing roles of androgen receptor/YAP/miRNAs axis in prostate cancer metastasis
Cancer Science. 2024 Mar;115(Suppl. 1):1299.
2022-07
Caffeic acid phenethyl ester suppresses drug resistance of enzalutamide or abiraterone in prostate cancer cells
Annals of Oncology. 2022 Jul;33(Suppl. 6):S493-S494.
2022-02
Aspalathus linearis suppresses AKT signaling, c-Myc, AR and survival of enzalutamide-resistant prostate cancer cells
Cancer Science. 2022 Feb;113(S1):1338.
2019-10
ACTL6A is a novel oncogene and prognostic biomarker for prostate cancer
Annals of Oncology. 2019 Oct;30(Suppl. 6):Abstract number MO2-10-6.
2018-12
KDM4C promotes prostate cancer metastasis via modulation of c-Myc and metabolic enzymes
Cancer Science. 2018 Dec;109(Suppl. 2):1241.
2018-12
CD44 promotes migration ability of docetaxel-resistant prostate cancer cells via induction of Hippo-Yap signaling
Cancer Science. 2018 Dec;109(Suppl. 2):990.
2018-12
Caffeic Acid Phenethyl Ester (CAPE) suppresses protein expression level of AR-V7 in human prostate cancer
Cancer Science. 2018 Dec;109(Suppl. 2):995.
2018-12
Different role of androgen receptor in regulation of prostate cancer metastasis with or without androgen
Cancer Science. 2018 Dec;109(Suppl. 2):996.
2018-12
Rooibos suppresses the proliferation of human castration-resistant prostate cancer cells
Cancer Science. 2018 Dec;109(Suppl. 2):575.
2018-12
Down-regulation of ROR2 promotes prostate cancer metastasis through regulation of miRNAs on PIAS3 expression
Cancer Science. 2018 Dec;109(Suppl. 2):443.
2018-12
The anti-proliferative effect of CAPE on docetaxel-resistant prostate cancer cells
Cancer Science. 2018 Dec;109(Suppl. 2):574.
2018-12
ACTL6a promotes metastasis and predicts poor prognosis of prostate cancer via regulation of YAP and cancer stemness
Cancer Science. 2018 Dec;109(Suppl. 2):244.
2018-10
Histone demethylase KDM4C is a novel oncogene and prognostic biomarker for prostate cancer
Annals of Oncology. 2018 Oct;29(Suppl. 7):Meeting Abstract O1-19-2.
2018-01
KDM4C: A novel oncogene and prognostic biomarker for prostate cancer
Cancer Science. 2018 Jan;109(Suppl. 1):1073.
2018-01
Role of ACTL6A in human prostate cancer cell
Cancer Science. 2018 Jan;109(Suppl. 1):1074.
2017-10
Non-Canonical Wnt receptor ROR2 suppresses prostate cancer metastasis
Annals of Oncology. 2017 Oct;28(Suppl. 9):Meeting Abstract P1-284.
2016
YAP Promotes Myogenic Differentiation via the MEK5-ERK5 pathway
Molecular Biology of the Cell. 2016;27:E144.
2015-11
Proteomics profiling of epigenetic proteins during acinar morphogenesis to identify prostate cancer prognostic markers
Annals of Oncology. 2015 Nov;26:vii106-vii151.
2014-07
SWAP-70 is required for spontaneous transformation of mouse embryo fibroblasts
European Journal of Cancer. 2014 Jul;50(Suppl. 5):S23.
2012-04
Application of high-throughput proteomics Micro-Western array in studying molecular mechanism of anticancer effect of liver X receptor agonists against human colon cancer cells
Cancer Research. 2012 Apr;72:Abstract number 1276.
顯示項目1-23 / 23. (共1頁)
1
每頁顯示[
10
|
25
|
50
]項目
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
回饋